Howard Horn

Insider Reports History

Location
Novato, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Horn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Chief Financial Officer Common Stock 85,034 $1,904,761 $22.40 03 Mar 2026 Direct
Vir Biotechnology, Inc. CFO Common Stock 230,712 $352,989 $1.53 23 Feb 2023 Direct
Ultragenyx Pharmaceutical Inc. Chief Financial Officer Stock Option (Right to Buy) 28,160 01 Mar 2025 Direct

Insider Reports Filed by Howard Horn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2026 4 -$227,538 4 Chief Financial Officer 03 Mar 2026, 18:50
RARE Ultragenyx Pharmaceutical Inc. 02 Feb 2026 1 -$72,117 4 Chief Financial Officer 03 Feb 2026, 12:00
RARE Ultragenyx Pharmaceutical Inc. 02 Jan 2026 1 -$71,946 4 Chief Financial Officer 05 Jan 2026, 16:07
RARE Ultragenyx Pharmaceutical Inc. 10 Dec 2025 1 -$112,087 4 Chief Financial Officer 11 Dec 2025, 12:10
RARE Ultragenyx Pharmaceutical Inc. 13 Oct 2025 1 -$250,252 4 Chief Financial Officer 14 Oct 2025, 12:15
RARE Ultragenyx Pharmaceutical Inc. 06 Mar 2025 1 -$72,114 4 Chief Financial Officer 10 Mar 2025, 12:53
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2025 2 $0 4 Chief Financial Officer 04 Mar 2025, 19:56
RARE Ultragenyx Pharmaceutical Inc. 10 Oct 2024 1 -$393,853 4 Chief Financial Officer 11 Oct 2024, 16:48
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2024 2 $0 4 Chief Financial Officer 05 Mar 2024, 20:23
RARE Ultragenyx Pharmaceutical Inc. 09 Oct 2023 2 $0 4 Chief Financial Officer 10 Oct 2023, 12:50
RARE Ultragenyx Pharmaceutical Inc. 09 Oct 2023 0 $0 3 Chief Financial Officer 10 Oct 2023, 12:48
VIR Vir Biotechnology, Inc. 23 Feb 2023 1 -$58,387 4 CFO 24 Feb 2023, 19:36
VIR Vir Biotechnology, Inc. 17 Feb 2023 1 -$61,298 4 CFO 21 Feb 2023, 18:22
VIR Vir Biotechnology, Inc. 22 Feb 2022 2 $0 4 CFO 24 Feb 2022, 20:29
VIR Vir Biotechnology, Inc. 17 Feb 2022 1 -$76,411 4 CFO 22 Feb 2022, 16:00